Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Recode Ventures is a venture capital firm founded in 2022 and headquartered in the United States. The firm specializes in early-stage investments, particularly in healthcare companies at the seed and Series A stages. With a mission to support innovative founders, Recode Ventures focuses on startups that leverage technology to transform healthcare delivery and outcomes. The firm has quickly established a reputation for its commitment to investing at the intersection of healthcare and technology, emphasizing the importance of deep tech in addressing significant global health challenges.
Since its inception, Recode Ventures has raised a portfolio of seven companies, showcasing its ability to identify and nurture promising startups in the healthcare sector. The firm’s leadership is dedicated to fostering innovation and supporting entrepreneurs who are pioneering solutions in healthcare. By concentrating on sectors such as artificial intelligence, biotechnology, and advanced medical technologies, Recode Ventures aims to drive meaningful change in the healthcare landscape.
Recode Ventures invests in companies that operate at the intersection of healthcare and technology, with a strong emphasis on early-stage ventures. The firm’s investment thesis is centered around the convergence of deep tech and healthcare, targeting sectors such as machine learning, nanotechnology, robotics, and augmented reality. This focus allows Recode Ventures to back startups that are not only innovative but also capable of addressing pressing health challenges through technological advancements.
The firm is particularly interested in companies that are developing solutions to improve patient outcomes, streamline healthcare processes, and enhance the overall efficiency of healthcare delivery. By investing in seed and Series A stages, Recode Ventures provides crucial support to founders who are at the forefront of healthcare innovation. The firm seeks to partner with visionary entrepreneurs who are leveraging cutting-edge technologies to create impactful solutions in the healthcare space.
Recode Ventures has built a diverse portfolio of seven notable companies, each contributing to the advancement of healthcare through innovative technologies. Among its investments is **Caption Care**, which focuses on heart disease detection and management through convenient echocardiograms. Another key portfolio company, **Probably Genetic**, aims to expedite the diagnosis process for patients with rare conditions using a proprietary platform.
**Lab Genius** combines human and machine intelligence to accelerate the discovery of advanced medicines, while **Waypoint Bio** utilizes spatial biology and AI/ML to design better cell therapies for cancer. **Proprio** enhances surgical planning and execution through advanced AR/VR technologies, and **Nanograb** employs computational biology and AI to target genetic drugs to specific tissues. Lastly, **Sensible Biotechnologies** develops mRNA for therapeutic applications using novel design approaches. This portfolio reflects Recode Ventures' commitment to supporting transformative healthcare solutions that leverage technology.
To pitch Recode Ventures, founders should visit their contact page at recodeventures.com/contact. The firm is open to pitches that highlight innovative healthcare solutions, and they encourage direct outreach through this platform.
Recode Ventures primarily invests in early-stage companies, specifically at the seed and Series A stages. This focus allows the firm to support startups that are in the initial phases of development and are looking to scale their innovative healthcare solutions.
Founders interested in pitching to Recode Ventures can do so through their contact page at recodeventures.com/contact. The firm welcomes pitches that clearly articulate the innovative aspects of the healthcare solutions being proposed.
Recode Ventures focuses on the intersection of healthcare and technology, investing in sectors such as artificial intelligence, biotechnology, machine learning, nanotechnology, robotics, and augmented reality. This diverse focus allows the firm to back companies that are addressing significant health challenges through technological innovation.
The specific check size for investments by Recode Ventures is not publicly disclosed. However, as a firm focused on seed and Series A stages, they typically provide funding that aligns with the needs of early-stage healthcare startups.
Recode Ventures primarily invests in companies based in the United States. The firm is dedicated to supporting local entrepreneurs who are innovating in the healthcare sector.
While specific details on portfolio support are not provided, Recode Ventures is committed to partnering with founders to help them navigate the challenges of building a startup in the healthcare space. This includes leveraging their network and expertise to facilitate growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.